news
Launch of the anti-cancer agent / BRAF inhibitor “Zelboraf”
26 February 2015 | By Roche
Contribution to the treatment of melanoma by personalized healthcare...
List view / Grid view
Roche
news
Patrice Denèfle is the new Head of the Roche Institute for Research and Translational Medicine, created by Roche France
19 February 2015 | By Roche
The Institute’s mission is to consolidate and expand R&D partnerships in France with Centres of Excellence in translational Medicine...
news
Roche, Meiji and Fedora join forces to tackle increasing bacterial resistance to antibiotics
13 January 2015 | By Roche
Roche, Meiji Seika Pharma (Meiji) and Fedora announced that they have entered into a license agreement for the development and commercialization of OP0595, a beta-lactamase inhibitor in phase I clinical development...
news
Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology
12 January 2015 | By Roche
Collaboration leverages both companies’ strengths to advance the progress of personalized treatments for patients with cancer...
news
FDA approves Roche’s cobas® TaqScreen MPX Test, v2.0 for use in the detection and identification of HIV, HCV, and HBV
9 January 2015 | By Roche
FDA Approves Roche’s Blood Screening Assay for Simultaneous Detection and Identification of Three Major Viral Targets. cobas TaqScreen MPX Test, v2.0 offers enhanced sensitivity and workflow advantages...
news
Roche purchases shares in tender offer for InterMune, Inc.
30 September 2014 | By Roche
Roche and InterMune, Inc. announced that Roche’s wholly owned subsidiary Klee Acquisition Corporation has accepted for payment all shares validly tendered pursuant to its tender offer for all outstanding shares of common stock of InterMune, Inc. at USD 74.00 per share in cash...
news
EATRIS enters framework agreement with Roche to access Europe-wide network of translational researchers
26 September 2014 | By EATRIS
EATRIS has signed a formal framework agreement with the Roche Partnering Extending Innovation Network (EIN) program...
news
Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines
5 August 2014 | By Roche
Roche announced that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark...
news
Roche’s RoACTEMRA receives CHMP positive opinion in Europe for use in patients with early rheumatoid arthritis (RA) not previously treated with methotrexate (MTX)
4 August 2014 | By Roche
Roche announced that RoACTEMRA (tocilizumab, also known as ACTEMRA) has received a positive opinion from the Committee for Medicinal Products for Human Use for use in Europe...
news
AstraZeneca and Roche announce partnership to develop companion diagnostic test for AZD9291
28 July 2014 | By AstraZeneca
AstraZeneca announced it has entered into collaboration with Roche to develop a plasma-based companion diagnostic test to support AZD9291...
news
Roche announces phase II clinical results of crenezumab in Alzheimer’s disease
17 July 2014 | By Roche
Roche presented data from two phase II studies investigating whether crenezumab can delay cognitive and functional decline in people with mild-to-moderate Alzheimer’s disease...
news
Roche announces definitive agreement to acquire Seragon Pharmaceuticals
2 July 2014 | By Roche
Roche announced that Genentech has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc. (Seragon), a privately held biotechnology company based in San Diego, California, USA...
news
Roche acquires Genia Technologies to strengthen next generation sequencing pipeline
2 June 2014 | By Roche
Roche announced the acquisition of Genia Technologies, Inc., a privately held company, based in Mountain View, California, USA...
news
Roche acquires IQuum to strengthen offerings in molecular diagnostics
7 April 2014 | By Roche
IQuum’s unique products will allow Roche to quickly enter the point of care segment of molecular diagnostics...
news
Roche’s lebrikizumab phase IIb data show reduction of asthma attack rates and improvement of lung function in adult patients with severe uncontrolled asthma
5 March 2014 | By Roche
Roche presented new data from the LUTE / VERSE phase IIb studies investigating lebrikizumab in patients with severe uncontrolled asthma...